Predictors of dynamic hyperinflation during the 6-minute walk test in stable chronic obstructive pulmonary disease patients

Journal of Thoracic Disease

Volumn 7, Issue 7, 2015, Pages 1142-1150

  Chen, Rui ^a   Lin, Lin ^a   Tian, Jing Wei ^a   Zeng, Bin ^b   Zhang, Lei ^b   Chen, Xin ^c   Yan, Hai Yan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Provincial Hospital   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease (COPD); Dynamic hyperinflation (DH); Exercise capacity; Inspiratory capacity (IC)

Indexed keywords

6 MINUTE WALK TEST; AGE DISTRIBUTION; AGED; ARTICLE; BORG DYSPNEA SCALE; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE COURSE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE SCORE; HUMAN; INSPIRATORY CAPACITY; LUNG COMPLICATION; LUNG DYNAMIC HYPERINFLATION; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; OXYGEN SATURATION; PREDICTOR VARIABLE; QUALITY OF LIFE; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TOTAL LUNG CAPACITY; WALKING DIFFICULTY;

EID: 84939613948     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.07.08     Document Type: Article

References (33)

1. Pepin V, Saey D, Laviolette L, et al. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD 2007;4:195-204.
2. O'Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol (1985) 2008;105:753-5.
3. Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005;128:2025-34.
4. Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:1541-51.
5. Chen R, Tian JW, Zhou LQ, et al. The relationship between sleep quality and functional exercise capacity in COPD. Clin Respir J 2014. [Epub ahead of print].
6. Callens E, Graba S, Gillet-Juvin K, et al. Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD. Chest 2009;136:1466-72.
7. Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1395-9.
8. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
9. Scuarcialupi ME, Berton DC, Cordoni PK, et al. Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? J Bras Pneumol 2014;40:111-8.
10. Baldi BG, de Albuquerque AL, Pimenta SP, et al. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM. Respir Med 2013;107:1773-80.
11. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
12. Zheng J, Zhong N. Normative values of pulmonary function testing in Chinese adults. Chin Med J (Engl) 2002;115:50-4.
13. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-65.
14. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
15. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81.
16. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:55-9.
17. Al-shair K, Dockry R, Mallia-Milanes B, et al. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 2009;103:1572-9.
18. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
19. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD 2012;9:12-5.
20. Hannink J, Lahaije A, Bischoff E, et al. Dynamic hyperinflation after metronome-paced hyperventilation in COPD-a 2 year follow-up. Respir Med 2010;104:1700-5.
21. Gagnon P, Guenette JA, Langer D, et al. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:187-201.
22. Leivo-Korpela S, Lehtimäki L, Vuolteenaho K, et al. Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD. Respir Med 2014;108:122-8.
23. Zafar MA, Tsuang W, Lach L, et al. Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease. Lung 2013;191:177-82.
24. Kitahara Y, Hattori N, Yokoyama A, et al. Cigarette smoking decreases dynamic inspiratory capacity during maximal exercise in patients with type 2 diabetes. Hiroshima J Med Sci 2012;61:29-36.
25. Stewart JI, Criner GJ. The small airways in chronic obstructive pulmonary disease: pathology and effects on disease progression and survival. Curr Opin Pulm Med 2013;19:109-15.
26. O'Donnell DE, Travers J, Webb KA, et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009;34:866-74.
27. Guenette JA, Webb KA, O'Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J 2012;40:322-9.
28. Kyoh S, Kanazawa H, Tochino Y, et al. Comparison of N-epsilon-(Carboxymethyl) Lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma. Med Sci Monit 2008;14:CR375-8.
29. Guillemi S, Wright JL, Hogg JC, et al. Density dependence of pulmonary resistance: correlation with small airway pathology. Eur Respir J 1995;8:789-94.
30. Kobayashi D, Tochino Y, Kanazawa H, et al. Comparison of alveolar nitric oxide concentrations using two different methods for assessing small airways obstruction in asthma. Respirology 2011;16:862-8.
31. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567-75.
32. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
33. van Gestel AJ, Kohler M, Steier J, et al. Cardiac autonomic function and cardiovascular response to exercise in patients with chronic obstructive pulmonary disease. COPD 2012;9:160-5.